Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ValiRx PLC (GB:VAL)
LSE:VAL
Holding GB:VAL?
Track your performance easily
VAL Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.61p - 5.05p
Previous CloseN/A
Volume1.58M
Average Volume (3M)17.88M
Market Cap
£2.99M
Enterprise Value3.00M
Total Cash (Recent Filing)$560.76K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Apr 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding374,348,660
10 Day Avg. Volume15,264,111
30 Day Avg. Volume17,876,992
Standard Deviation0.40
R-Squared0.01
Alpha0.00749
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)311.96
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit367.28
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ValiRx plc News
PremiumCompany Announcements
ValiRx Extends Evaluation Agreement for Cancer Therapeutics Research
PremiumCompany Announcements
ValiRx Partners with Altus for Innovative Cancer Treatment Evaluation
PremiumCompany Announcements
ValiRx PLC Announces Change in Major Holdings
PremiumCompany Announcements
ValiRx PLC Announces Change in Voting Rights Holdings
PremiumCompany Announcements
ValiRx Announces Change in Major Shareholder Voting Rights
PremiumCompany Announcements
ValiRx Announces Changes in Major Shareholdings
PremiumCompany Announcements
ValiRx PLC Reports Change in Major Shareholder Holdings
PremiumCompany Announcements
ValiRx plc Announces Change in Major ShareholdingsOptions Prices
Currently, No data available
---
Ownership Overview
VAL FAQ
What was ValiRx PLC’s price range in the past 12 months?
ValiRx PLC lowest share price was 0.61p and its highest was 5.05p in the past 12 months.
What is ValiRx PLC’s market cap?
ValiRx PLC’s market cap is £2.99M.
When is ValiRx PLC’s upcoming earnings report date?
ValiRx PLC’s upcoming earnings report date is Apr 15, 2025 which is in 74 days.
How were ValiRx PLC’s earnings last quarter?
ValiRx PLC released its earnings results on Sep 27, 2024. The company reported -0.007p earnings per share for the quarter, missing the consensus estimate of N/A by -0.007p.
Is ValiRx PLC overvalued?
According to Wall Street analysts ValiRx PLC’s price is currently Overvalued.
Does ValiRx PLC pay dividends?
ValiRx PLC does not currently pay dividends.
What is ValiRx PLC’s EPS estimate?
ValiRx PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ValiRx PLC have?
ValiRx PLC has 374,348,660 shares outstanding.
What happened to ValiRx PLC’s price movement after its last earnings report?
ValiRx PLC reported an EPS of -0.007p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.706%.
Which hedge fund is a major shareholder of ValiRx PLC?
Currently, no hedge funds are holding shares in GB:VAL
---
Company Description
ValiRx PLC
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in the epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.
---
Technical Analysis
---